| Package | silth.fhir.terminology.core |
| Resource Type | CodeSystem |
| Id | cs-thcc-allergy-manifest |
| FHIR Version | R5 |
| Source | https://terms.sil-th.org/core/https://terms.sil-th.org/core/STU1/CodeSystem-cs-thcc-allergy-manifest.html |
| URL | https://terms.sil-th.org/core/CodeSystem/cs-thcc-allergy-manifest |
| Version | 0.1.2 |
| Status | active |
| Date | 2023-10-11T23:15:12+07:00 |
| Name | CS_THCC_AllergyManifest |
| Title | THCC: รหัสลักษณะอาการแพ้ยาที่พบ |
| Description | รหัสลักษณะอาการแพ้ยาที่พบ โดย THCC (ID: 68) |
| Content | complete |
| ValueSet | |
| vs-thcc-allergy-manifest | THCC: รหัสลักษณะอาการแพ้ยาที่พบ |
No resources found
Note: links and images are rebased to the (stated) source
This case-insensitive code system https://terms.sil-th.org/core/CodeSystem/cs-thcc-allergy-manifest defines the following codes:
{
"resourceType": "CodeSystem",
"id": "cs-thcc-allergy-manifest",
"meta": {
"profile": [
"http://hl7.org/fhir/StructureDefinition/shareablecodesystem"
]
},
"text": {
"status": "generated",
"div": "<!-- snip (see above) -->"
},
"url": "https://terms.sil-th.org/core/CodeSystem/cs-thcc-allergy-manifest",
"version": "0.1.2",
"name": "CS_THCC_AllergyManifest",
"title": "THCC: รหัสลักษณะอาการแพ้ยาที่พบ",
"status": "active",
"experimental": false,
"date": "2023-10-11T23:15:12+07:00",
"publisher": "Standards and Interoperability Lab - Thailand (SIL-TH)",
"contact": [
{
"name": "Standards and Interoperability Lab - Thailand (SIL-TH)",
"telecom": [
{
"system": "url",
"value": "https://www.sil-th.org"
}
]
}
],
"description": "รหัสลักษณะอาการแพ้ยาที่พบ โดย THCC (ID: 68)",
"caseSensitive": false,
"content": "complete",
"count": 39,
"concept": [
{
"code": "01",
"display": "D59.0",
"definition": "Drug-induced autoimmune hemolytic anemia"
},
{
"code": "02",
"display": "D59.2",
"definition": "Drug-induced non autoimmune hemolytic anemia"
},
{
"code": "03",
"display": "D60.1",
"definition": "Transient acquired pure red cell aplasic"
},
{
"code": "04",
"display": "D61.1",
"definition": "Drug-induced aplastic anemia"
},
{
"code": "05",
"display": "D64.2",
"definition": "Secondary sideroblastic anemia due to drugs and toxic"
},
{
"code": "06",
"display": "D68.3",
"definition": "Haemorrhagic disorders due to circulating anticoagulants"
},
{
"code": "07",
"display": "D70",
"definition": "Agranolocytosis"
},
{
"code": "08",
"display": "G21.0",
"definition": "Malignant neuroleptic syndrome"
},
{
"code": "09",
"display": "G21.1",
"definition": "Other drugs-induced secondary parkinsonism"
},
{
"code": "10",
"display": "G25.1",
"definition": "Drug-induced tremor"
},
{
"code": "11",
"display": "G25.6",
"definition": "Drug-induced tremor and other tias of organic crign"
},
{
"code": "12",
"display": "G44.4",
"definition": "Drugs - induced headocin, not elsewhere"
},
{
"code": "13",
"display": "G72.0",
"definition": "Drugs - induced myopathy classified"
},
{
"code": "14",
"display": "G93",
"definition": "Toxic encephalopathy"
},
{
"code": "15",
"display": "H40.6",
"definition": "glaucon secondary to drugs"
},
{
"code": "16",
"display": "H26.3",
"definition": "Drug-induced catarat"
},
{
"code": "17",
"display": "I42.7",
"definition": "Cardiomyopathy due to drugs and other external drugs"
},
{
"code": "18",
"display": "I95.2",
"definition": "Hypotension due to drugs"
},
{
"code": "19",
"display": "L23.3",
"definition": "Allergic contact dermatitis due to drugs in contact With skin"
},
{
"code": "20",
"display": "L24.4",
"definition": "Irritant contact dermatitis due to drugs in contact with skin"
},
{
"code": "21",
"display": "L25.1",
"definition": "Unspecified contact dermatitis due to drugs in contact with skin"
},
{
"code": "22",
"display": "L26",
"definition": "Exfoliative dermatitis"
},
{
"code": "23",
"display": "L27.0",
"definition": "Generalized skin eruption due to drugs and medicaments"
},
{
"code": "24",
"display": "L27.10",
"definition": "Fixed drugs eruption"
},
{
"code": "25",
"display": "L27.18",
"definition": "Other specified localized skin eruption due to drugs and medicaments"
},
{
"code": "26",
"display": "L27.19",
"definition": "Localized skin eruption due to drugs and medicaments, unspecified"
},
{
"code": "27",
"display": "L50.0",
"definition": "Allergic urticaria"
},
{
"code": "28",
"display": "L50.6",
"definition": "Contact urticaria"
},
{
"code": "29",
"display": "L51.0",
"definition": "Nombullous erythema multiforne"
},
{
"code": "30",
"display": "L51.1",
"definition": "Bullous erythema multiforme"
},
{
"code": "31",
"display": "L51.8",
"definition": "Other erythema multifonme"
},
{
"code": "32",
"display": "L51.9",
"definition": "Erythema multiforme, unspecified"
},
{
"code": "33",
"display": "M10.2",
"definition": "Drug-induced gout"
},
{
"code": "34",
"display": "M62.8",
"definition": "Rhabdornylysis"
},
{
"code": "35",
"display": "M80.4",
"definition": "Drug-induced osteoporosis with pathological factors"
},
{
"code": "36",
"display": "M81.4",
"definition": "Drug-induced osteoporosis"
},
{
"code": "37",
"display": "N14.0",
"definition": "Analgesic nephropatic"
},
{
"code": "38",
"display": "N14.1",
"definition": "Nephropathy induced by other drugs, medicaments and biological substuces"
},
{
"code": "39",
"display": "N14.2",
"definition": "toxic nephropathy, not elsewhere classified"
}
]
}